Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Restructuring Charges (Details)

v3.22.4
Basis of Presentation and Summary of Significant Accounting Policies - Restructuring Charges (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2022
Protein Sciences [Member] | QT Holdings Corporation [Member]        
Accrued restructuring actions balances $ 1,247      
Restructuring costs   $ 2,170    
Cash payments (1,015) (851)    
Adjustments (111) (72)    
Accrued restructuring actions balances 121 1,247    
Diagnostics and Genomics [Member]        
Restructuring costs     $ 1,185 $ 242
Cash payments       (1,143)
Adjustments       (284)
Selling, General and Administrative Expenses [Member] | Protein Sciences [Member]        
Restructuring costs   2,170    
Selling, General and Administrative Expenses [Member] | Diagnostics and Genomics [Member]        
Restructuring costs       1,399
Employee Severance [Member] | Protein Sciences [Member]        
Restructuring costs   780    
Cash payments (176)      
Accrued restructuring actions balances 604      
Employee Severance [Member] | Protein Sciences [Member] | QT Holdings Corporation [Member]        
Accrued restructuring actions balances 908      
Restructuring costs   1,328    
Cash payments (753) (420)    
Adjustments (38)      
Accrued restructuring actions balances 117 908    
Employee Severance [Member] | Diagnostics and Genomics [Member]        
Restructuring costs     639  
Cash payments       (589)
Adjustments       (50)
Employee Severance [Member] | Selling, General and Administrative Expenses [Member] | Protein Sciences [Member]        
Restructuring costs   1,328    
Employee Severance [Member] | Selling, General and Administrative Expenses [Member] | Diagnostics and Genomics [Member]        
Restructuring costs       649
Asset Impairment and Other [Member] | Protein Sciences [Member] | QT Holdings Corporation [Member]        
Accrued restructuring actions balances 339      
Restructuring costs   842    
Cash payments (262) (431)    
Adjustments (73) (72)    
Accrued restructuring actions balances $ 4 339    
Asset Impairment and Other [Member] | Diagnostics and Genomics [Member]        
Restructuring costs     $ 546 242
Cash payments       (554)
Adjustments       (234)
Asset Impairment and Other [Member] | Selling, General and Administrative Expenses [Member] | Protein Sciences [Member]        
Restructuring costs   $ 842    
Asset Impairment and Other [Member] | Selling, General and Administrative Expenses [Member] | Diagnostics and Genomics [Member]        
Restructuring costs       $ 750